MX2015015899A - Metodos para producir particulas que comprenden proteinas terapeuticas. - Google Patents
Metodos para producir particulas que comprenden proteinas terapeuticas.Info
- Publication number
- MX2015015899A MX2015015899A MX2015015899A MX2015015899A MX2015015899A MX 2015015899 A MX2015015899 A MX 2015015899A MX 2015015899 A MX2015015899 A MX 2015015899A MX 2015015899 A MX2015015899 A MX 2015015899A MX 2015015899 A MX2015015899 A MX 2015015899A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- therapeutic proteins
- produce particles
- particles
- produce
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/241—Tumor Necrosis Factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Endocrinology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
La presente invención se refiere a métodos para producir una partícula que comprende una matriz polimérica y una proteína.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13168674.3A EP2805708A1 (en) | 2013-05-22 | 2013-05-22 | Methods to produce particles comprising therapeutic proteins |
EP14161988 | 2014-03-27 | ||
PCT/EP2014/060450 WO2014187863A1 (en) | 2013-05-22 | 2014-05-21 | Methods to produce particles comprising therapeutic proteins |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2015015899A true MX2015015899A (es) | 2016-07-15 |
Family
ID=50877246
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015015899A MX2015015899A (es) | 2013-05-22 | 2014-05-21 | Metodos para producir particulas que comprenden proteinas terapeuticas. |
Country Status (14)
Country | Link |
---|---|
US (1) | US20160090415A1 (es) |
EP (1) | EP2999459A1 (es) |
JP (1) | JP2016519152A (es) |
KR (1) | KR20160009690A (es) |
CN (1) | CN105338961A (es) |
AU (1) | AU2014270439A1 (es) |
BR (1) | BR112015028986A2 (es) |
CA (1) | CA2912730A1 (es) |
CL (1) | CL2015003420A1 (es) |
EA (1) | EA201592222A1 (es) |
HK (1) | HK1214964A1 (es) |
MX (1) | MX2015015899A (es) |
SG (1) | SG11201509450QA (es) |
WO (1) | WO2014187863A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2019528248A (ja) | 2016-07-18 | 2019-10-10 | ティシュージェン, インク. | 生体分子の立体配座及び構造健全性を維持するための方法及び組成物 |
CN112336873B (zh) * | 2020-08-04 | 2022-04-19 | 华南理工大学 | 用于多特异性抗体递送的蛋白型纳米颗粒及其应用、制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100201352B1 (ko) * | 1995-03-16 | 1999-06-15 | 성재갑 | 단일주사 백신 제형 |
EP2044934A1 (en) * | 2007-10-01 | 2009-04-08 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Dispersion of poloxamer-protein particles, methods of manufacturing and uses thereof |
-
2014
- 2014-05-21 KR KR1020157035935A patent/KR20160009690A/ko not_active Application Discontinuation
- 2014-05-21 US US14/892,325 patent/US20160090415A1/en not_active Abandoned
- 2014-05-21 BR BR112015028986A patent/BR112015028986A2/pt not_active IP Right Cessation
- 2014-05-21 EP EP14727442.7A patent/EP2999459A1/en not_active Withdrawn
- 2014-05-21 JP JP2016514394A patent/JP2016519152A/ja active Pending
- 2014-05-21 EA EA201592222A patent/EA201592222A1/ru unknown
- 2014-05-21 WO PCT/EP2014/060450 patent/WO2014187863A1/en active Application Filing
- 2014-05-21 SG SG11201509450QA patent/SG11201509450QA/en unknown
- 2014-05-21 MX MX2015015899A patent/MX2015015899A/es unknown
- 2014-05-21 CA CA2912730A patent/CA2912730A1/en not_active Abandoned
- 2014-05-21 AU AU2014270439A patent/AU2014270439A1/en not_active Abandoned
- 2014-05-21 CN CN201480037271.2A patent/CN105338961A/zh active Pending
-
2015
- 2015-11-20 CL CL2015003420A patent/CL2015003420A1/es unknown
-
2016
- 2016-03-15 HK HK16102997.1A patent/HK1214964A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
CN105338961A (zh) | 2016-02-17 |
EP2999459A1 (en) | 2016-03-30 |
JP2016519152A (ja) | 2016-06-30 |
CA2912730A1 (en) | 2014-11-27 |
CL2015003420A1 (es) | 2016-09-30 |
WO2014187863A1 (en) | 2014-11-27 |
HK1214964A1 (zh) | 2016-08-12 |
US20160090415A1 (en) | 2016-03-31 |
AU2014270439A1 (en) | 2015-12-17 |
EA201592222A1 (ru) | 2016-08-31 |
SG11201509450QA (en) | 2015-12-30 |
BR112015028986A2 (pt) | 2017-07-25 |
KR20160009690A (ko) | 2016-01-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ711445A (en) | Fusion immunomodulatory proteins and methods for making same | |
HK1206636A1 (en) | Modified polynucleotides for the production of oncology-related proteins and peptides | |
EP2991670B8 (en) | Sobetirome in the treatment of myelination diseases | |
MX2015006324A (es) | Metodos para la fabricacion de polipeptidos proteoliticamente procesados. | |
MX365612B (es) | Polipeptidos de factor x modificados y usos de los mismos. | |
MX366317B (es) | Composiciones y metodos para tratar la inflamacion cronica y las enfermedades inflamatorias. | |
EP3325010A4 (en) | ANTIBODIES AGAINST COZY FACTOR XIA AND USES THEREOF | |
AU355322S (en) | Chair | |
EP3020733A4 (en) | Core-shell crosslinked hyaluronic acid gel particles, production method for same, and medical material | |
MX365403B (es) | Peptidos y metodos para usarlos. | |
PL2986633T3 (pl) | Sposoby ekspresji peptydów i białek | |
JOP20210010A1 (ar) | بروتينات مخصصة ل baff و b7rp1 وإستخداماتها | |
MD20150109A2 (ro) | Construcţii proteice mitocondriale şi utilizările acestora | |
EP2990414A4 (en) | POLYPEPTIDE PARTICLES AND METHOD FOR THE PRODUCTION THEREOF | |
EP3070106A4 (en) | Composite particles, method for producing same, and use thereof | |
HK1206763A1 (en) | Charged nutritive fragments, proteins and methods | |
EP2987531A4 (en) | PARTICULATE THERAPY SYSTEM | |
EP2984935A4 (en) | PROTEIN COMPOSITION AND METHOD FOR MANUFACTURING THE SAME | |
EP3008188A4 (en) | Protein production in plants | |
EP2976362A4 (en) | Antibodies and methods for treating estrogen receptor-associated diseases | |
ZA201505734B (en) | Methods for binding and precipitating gold using microbial-derived metallophores and their uses | |
MX2015015899A (es) | Metodos para producir particulas que comprenden proteinas terapeuticas. | |
SG11201506212PA (en) | Formulations and methods for increased recombinant protein production | |
EP3054010A4 (en) | Tumor antigen peptide | |
EP3020806A4 (en) | Tumor antigen peptide |